PDB: 165 resultsInfo pagesStatus searchChemie searchBIRD

---

8Y8Y	Crystal structure of the PTPN21 FERM domain Descriptor: CHLORIDE ION, Tyrosine-protein phosphatase non-receptor type 21 Authors: Lee, H.S, Ku, B. Deposit date: 2024-02-06 Release date: 2024-07-10 Method: X-RAY DIFFRACTION (2.099 Å) Cite: Structural analysis of the FERM domain of human protein tyrosine phosphatase non-receptor type 21. Acta Crystallogr.,Sect.F, 80, 2024
8TEC	Crystal structure of Kindlin2 in complex with acylated beta1 integrin peptide Descriptor: Fermitin family homolog 2, Integrin beta-1 Authors: Zhang, P.F, Wu, J.H. Deposit date: 2023-07-06 Release date: 2024-07-03 Method: X-RAY DIFFRACTION (2.04 Å) Cite: Acetyl-NPKY of integrin-beta 1 binds KINDLIN2 to control endothelial cell proliferation and junctional integrity. Iscience, 27, 2024
8TEE	Crystal structure of Kindlin2 in complex with K794Q mutated beta1 integrin Descriptor: Fermitin family homolog 2, Integrin beta-1 Authors: Zhang, P.F, Wu, J.H. Deposit date: 2023-07-06 Release date: 2024-07-03 Method: X-RAY DIFFRACTION (2.49 Å) Cite: Acetyl-NPKY of integrin-beta 1 binds KINDLIN2 to control endothelial cell proliferation and junctional integrity. Iscience, 27, 2024
8T7V	Co-crystal structure of KRIT1 with a 1-hydroxy 2-naphthaldehyde derivative (6-(furan-2-yl)-2-hydroxy-1-naphthaldehyde) Descriptor: (7M)-7-(furan-2-yl)-2-hydroxynaphthalene-1-carbaldehyde, Krev interaction trapped protein 1, MAGNESIUM ION, ... Authors: Bruystens, J.G.H. Deposit date: 2023-06-21 Release date: 2023-12-06 Method: X-RAY DIFFRACTION (2.25 Å) Cite: Targeted Reversible Covalent Modification of a Noncatalytic Lysine of the Krev Interaction Trapped 1 Protein Enables Site-Directed Screening for Protein-Protein Interaction Inhibitors. Acs Pharmacol Transl Sci, 6, 2023
8T09	Co-crystal structure of KRIT1 with a 1-hydroxy 2-naphthaldehyde derivative (6-ethynyl-2-hydroxy-1-naphthaldehyde) Descriptor: 6-ethynyl-2-hydroxynaphthalene-1-carbaldehyde, Krev interaction trapped protein 1, MAGNESIUM ION, ... Authors: Bruystens, J.G.H. Deposit date: 2023-05-31 Release date: 2023-12-13 Method: X-RAY DIFFRACTION (2.15 Å) Cite: Targeted Reversible Covalent Modification of a Noncatalytic Lysine of the Krev Interaction Trapped 1 Protein Enables Site-Directed Screening for Protein-Protein Interaction Inhibitors. Acs Pharmacol Transl Sci, 6, 2023
8T0D	Crystal structure of integrin beta-2 tail bound to the FERM-folded talin head domain with E269A/Y270A/K306Q triple mutation Descriptor: Integrin beta-2,Talin-1 Authors: Wu, J, Gao, T. Deposit date: 2023-05-31 Release date: 2024-07-03 Method: X-RAY DIFFRACTION (2.77 Å) Cite: Structure of Talin Bound to beta 2 Integrin Unveils the Molecular Mechanism of Species-Specific Integrin Activation Biorxiv, 2024
8SU8	Co-crystal structure of KRIT1 with a 1-hydroxy 2-naphthaldehyde derivative (6-(furan-2-yl)-2-hydroxy-1-naphthaldehyde). Descriptor: (6P)-6-(furan-2-yl)-2-hydroxynaphthalene-1-carbaldehyde, Krev interaction trapped protein 1, MAGNESIUM ION, ... Authors: Bruystens, J.G.H. Deposit date: 2023-05-11 Release date: 2023-12-06 Method: X-RAY DIFFRACTION (2.01 Å) Cite: Targeted Reversible Covalent Modification of a Noncatalytic Lysine of the Krev Interaction Trapped 1 Protein Enables Site-Directed Screening for Protein-Protein Interaction Inhibitors. Acs Pharmacol Transl Sci, 6, 2023
8CIS	The FERM domain of human moesin with two bound peptides identified by phage display Descriptor: 1,2-ETHANEDIOL, ACETATE ION, C3P, ... Authors: Bradshaw, W.J, Katis, V.L, Leisner, T.M, Fairhead, M, Bountra, C, von Delft, F, Pearce, K.H, Brennan, P.E. Deposit date: 2023-02-10 Release date: 2023-03-01 Last modified: 2023-11-29 Method: X-RAY DIFFRACTION (1.52 Å) Cite: Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's disease. J.Biol.Chem., 299, 2023
8CIU	The FERM domain of human moesin mutant H288A Descriptor: Moesin Authors: Bradshaw, W.J, Katis, V.L, Koekemoer, L, Bountra, C, von Delft, F, Brennan, P.E. Deposit date: 2023-02-10 Release date: 2023-03-01 Last modified: 2023-11-29 Method: X-RAY DIFFRACTION (2.393 Å) Cite: Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's disease. J.Biol.Chem., 299, 2023
8CIT	The FERM domain of human moesin mutant L281R Descriptor: Moesin Authors: Bradshaw, W.J, Katis, V.L, Koekemoer, L, Bountra, C, von Delft, F, Brennan, P.E. Deposit date: 2023-02-10 Release date: 2023-03-01 Last modified: 2023-11-29 Method: X-RAY DIFFRACTION (2.536 Å) Cite: Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's disease. J.Biol.Chem., 299, 2023
8CIR	The FERM domain of human moesin with a bound peptide identified by phage display Descriptor: 1,2-ETHANEDIOL, 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, BROMIDE ION, ... Authors: Bradshaw, W.J, Katis, V.L, Leisner, T.M, Fairhead, M, Bountra, C, von Delft, F, Pearce, K.H, Brennan, P.E. Deposit date: 2023-02-10 Release date: 2023-03-01 Last modified: 2023-11-29 Method: X-RAY DIFFRACTION (1.85 Å) Cite: Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's disease. J.Biol.Chem., 299, 2023
8FTB	Crystal structure of integrin beta-2 tail bound to the FERM-folded talin head domain with a K306Q mutation Descriptor: Integrin beta-2,Talin-1 Authors: Wu, J, Gao, T. Deposit date: 2023-01-11 Release date: 2024-07-03 Method: X-RAY DIFFRACTION (1.97 Å) Cite: Structure of Talin Bound to beta 2 Integrin Unveils the Molecular Mechanism of Species-Specific Integrin Activation Biorxiv, 2024
8FSE	Crystal structure of integrin beta-2 tail bound to the FERM-folded talin head domain Descriptor: Integrin beta-2,Talin-1 Authors: Wu, J, Gao, T. Deposit date: 2023-01-09 Release date: 2024-07-03 Method: X-RAY DIFFRACTION (1.9 Å) Cite: Structure of Talin Bound to beta 2 Integrin Unveils the Molecular Mechanism of Species-Specific Integrin Activation Biorxiv, 2024
8GXE	PTPN21 FERM PTP complex Descriptor: CHLORIDE ION, Tyrosine-protein phosphatase non-receptor type 21 Authors: Chen, L, Zheng, Y.Y, Zhou, C. Deposit date: 2022-09-19 Release date: 2023-09-27 Last modified: 2024-04-17 Method: X-RAY DIFFRACTION (3 Å) Cite: Structural analysis of PTPN21 reveals a dominant-negative effect of the FERM domain on its phosphatase activity. Sci Adv, 10, 2024
8GVL	PTPN21 FERM Descriptor: (4S)-2-METHYL-2,4-PENTANEDIOL, Tyrosine-protein phosphatase non-receptor type 21 Authors: Chen, L, Zheng, Y.Y, Zhou, C. Deposit date: 2022-09-15 Release date: 2023-09-20 Last modified: 2024-04-17 Method: X-RAY DIFFRACTION (2.1 Å) Cite: Structural analysis of PTPN21 reveals a dominant-negative effect of the FERM domain on its phosphatase activity. Sci Adv, 10, 2024
7EDR	The crystal structure of the FERM and C-terminal domain complex of Drosophila Merlin Descriptor: Moesin/ezrin/radixin homolog 2 Authors: Zhang, F, Long, J, Zhou, H. Deposit date: 2021-03-16 Release date: 2021-04-14 Last modified: 2023-11-29 Method: X-RAY DIFFRACTION (2.527 Å) Cite: The crystal structure of the FERM and C-terminal domain complex of Drosophila Merlin. Biochem.Biophys.Res.Commun., 553, 2021
7LWH	Human neurofibromin 2/merlin residues 1-339 in complex with LATS1 Descriptor: GLYCEROL, IMIDAZOLE, Merlin, ... Authors: Primi, M.C, Rangarajan, E.S, Izard, T. Deposit date: 2021-03-01 Release date: 2021-08-11 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (1.606 Å) Cite: Conformational flexibility determines the Nf2/merlin tumor suppressor functions. Matrix Biol Plus, 12, 2021
5RYP	EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1929757385 Descriptor: (3S)-1-(3-fluoropyridin-2-yl)-4,4-dimethylpyrrolidin-3-ol, 1,2-ETHANEDIOL, DIMETHYL SULFOXIDE, ... Authors: Bradshaw, W.J, Katis, V.L, Newman, J.A, von Delft, F, Arrowsmith, C.H, Edwards, A.M, Bountra, C, Gileadi, O. Deposit date: 2020-10-30 Release date: 2020-11-11 Last modified: 2024-03-06 Method: X-RAY DIFFRACTION (1.63 Å) Cite: EPB41L3 PanDDA analysis group deposition To Be Published
5RZ1	EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z27682767 Descriptor: 1,2-ETHANEDIOL, DIMETHYL SULFOXIDE, Isoform 2 of Band 4.1-like protein 3, ... Authors: Bradshaw, W.J, Katis, V.L, Newman, J.A, von Delft, F, Arrowsmith, C.H, Edwards, A.M, Bountra, C, Gileadi, O. Deposit date: 2020-10-30 Release date: 2020-11-11 Last modified: 2024-03-06 Method: X-RAY DIFFRACTION (1.62 Å) Cite: EPB41L3 PanDDA analysis group deposition To Be Published
5RZJ	EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434938 Descriptor: 1,2-ETHANEDIOL, 1-(5-methoxy-1H-indol-3-yl)-N,N-dimethyl-methanamine, DIMETHYL SULFOXIDE, ... Authors: Bradshaw, W.J, Katis, V.L, Newman, J.A, von Delft, F, Arrowsmith, C.H, Edwards, A.M, Bountra, C, Gileadi, O. Deposit date: 2020-10-30 Release date: 2020-11-11 Last modified: 2024-03-06 Method: X-RAY DIFFRACTION (1.68 Å) Cite: EPB41L3 PanDDA analysis group deposition To Be Published
5RZZ	EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1551999220 Descriptor: (2R)-3-(4-bromophenyl)-2-methylpropanamide, 1,2-ETHANEDIOL, DIMETHYL SULFOXIDE, ... Authors: Bradshaw, W.J, Katis, V.L, Newman, J.A, von Delft, F, Arrowsmith, C.H, Edwards, A.M, Bountra, C, Gileadi, O. Deposit date: 2020-10-30 Release date: 2020-11-11 Last modified: 2024-03-06 Method: X-RAY DIFFRACTION (1.76 Å) Cite: EPB41L3 PanDDA analysis group deposition To Be Published
5RZ7	EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z57472297 Descriptor: 1,2-ETHANEDIOL, 1-[2-methyl-1,3-bis(oxidanyl)propan-2-yl]-3-phenyl-urea, DIMETHYL SULFOXIDE, ... Authors: Bradshaw, W.J, Katis, V.L, Newman, J.A, von Delft, F, Arrowsmith, C.H, Edwards, A.M, Bountra, C, Gileadi, O. Deposit date: 2020-10-30 Release date: 2020-11-11 Last modified: 2024-03-06 Method: X-RAY DIFFRACTION (1.76 Å) Cite: EPB41L3 PanDDA analysis group deposition To Be Published
5RZQ	EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z100642432 Descriptor: 1,2-ETHANEDIOL, 2-bromo-4-fluoro-N,N-dimethylbenzamide, DIMETHYL SULFOXIDE, ... Authors: Bradshaw, W.J, Katis, V.L, Newman, J.A, von Delft, F, Arrowsmith, C.H, Edwards, A.M, Bountra, C, Gileadi, O. Deposit date: 2020-10-30 Release date: 2020-11-11 Last modified: 2024-03-06 Method: X-RAY DIFFRACTION (1.88 Å) Cite: EPB41L3 PanDDA analysis group deposition To Be Published
5RYM	EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z31217395 Descriptor: 1,2-ETHANEDIOL, DIMETHYL SULFOXIDE, Isoform 2 of Band 4.1-like protein 3, ... Authors: Bradshaw, W.J, Katis, V.L, Newman, J.A, von Delft, F, Arrowsmith, C.H, Edwards, A.M, Bountra, C, Gileadi, O. Deposit date: 2020-10-30 Release date: 2020-11-11 Last modified: 2024-03-06 Method: X-RAY DIFFRACTION (1.64 Å) Cite: EPB41L3 PanDDA analysis group deposition To Be Published
5RYY	EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z57257264 Descriptor: 1,2-ETHANEDIOL, 1-(3-phenylprop-2-yn-1-yl)piperidine, DIMETHYL SULFOXIDE, ... Authors: Bradshaw, W.J, Katis, V.L, Newman, J.A, von Delft, F, Arrowsmith, C.H, Edwards, A.M, Bountra, C, Gileadi, O. Deposit date: 2020-10-30 Release date: 2020-11-11 Last modified: 2024-03-06 Method: X-RAY DIFFRACTION (1.69 Å) Cite: EPB41L3 PanDDA analysis group deposition To Be Published

 

1234567>